Verona Pharma (VRP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

133.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 206.25
  • 52 Week Low: 125.00
  • Currency: UK Pounds
  • Shares Issued: 51.36m
  • Volume: 20,157
  • Market Cap: 68.31m
  • RiskGrade: 164

Verona Pharma Overview

Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe cough

1 Day Chart (28-04-2017)

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.0  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verona Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 n/a (2.57) (39.35)p n/a n/a n/a n/a 0.0%
31-Dec-13 n/a (2.81) (35.51)p n/a n/a n/a n/a 0.0%
31-Dec-14 n/a (3.76) (16.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (1,855.00)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (5.97) (749.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verona Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (14.05) (26.29)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a 55.26 109.15p 1.2 n/a n/a n/a 0.0%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

Latest Verona Pharma Director Deals

Traded Action Notifier PriceAmountValue
27-Apr-17 Buy David Ebsworth 168.75p 177,776 299,997.00
26-Apr-17 Buy David Ebsworth 132.00p 13,373 17,652.36
01-Mar-17 Buy Sven Jan-Anders Karlsson 149.00p 7,750 11,547.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 133.00p
Change Today -0.50p
% Change -0.37 %
52 Week High 206.25
52 Week Low 125.00
Volume 20,157
Shares Issued 51.36m
Market Cap 68.31m
RiskGrade 164

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.56% below the market average14.56% below the market average14.56% below the market average14.56% below the market average14.56% below the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average
Price Trend
77.94% below the market average77.94% below the market average77.94% below the market average77.94% below the market average77.94% below the market average
49.21% below the sector average49.21% below the sector average49.21% below the sector average49.21% below the sector average49.21% below the sector average
Income Not Available
Growth Not Available

Verona Pharma Dividends

No dividends found

Trades for 28-Apr-2017

Time Volume / Share Price
16:36 600 @ 135.00p
15:33 600 @ 135.00p
15:06 654 @ 131.11p
14:38 890 @ 131.00p
14:25 252 @ 131.11p

Verona Pharma Key Personnel

CEO Sven Jan-Anders Karlsson
CFO Piers Morgan

Top of Page